Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
Press Release |
January 20, 2011

Melanoma Patient and Memorial Efforts Fuel Advance...

WASHINGTON— For years, researchers in the melanoma field have worked tirelessly against funding shortfalls, a shortage of researchers and the complexities of the dise...

5 Minute Read
Blogs |
January 19, 2011

Linney Wins Golden Globe For Role as Melanoma Pati...

The Melanoma Research Foundation (MRF) was pleased to see Laura Linney’s portrayal of a woman with advanced melanoma honored by the Hollywood Foreign Press Associatio...

1 Minute Read
Melanoma News |
January 13, 2011

Pharmawire Examines New FDA Guidelines on Combina...

Pharmawire recently featured this article on the U.S. Food and Drug Administration’s (FDA) newly released draft guidelines for the co-development of combination thera...

1 Minute Read
Blogs |
December 27, 2010

The New York Times and Amy Harmon Cover Melanoma f...

The New York Times' latest installment in their ongoing coverage of melanoma focuses on the role that patients have in solving the problem of tumor resistance and spotl...

1 Minute Read
Melanoma News |
November 23, 2010

MRF Meets with FDA on State of Melanoma Drug Devel...

The Melanoma Research Foundation (MRF) met on November 15, 2010 with high-level officials at the Food and Drug Administration (FDA), including Dr. Richard Pazdur, the Direc...

2 Minute Read
Blogs |
November 9, 2010

In Memory of Jenna Bockmiller

Over the weekend the melanoma community lost a true fighter.  Jenna Bockmiller of California died at the age of 20, after a 6-year battle with melanoma. Her tenacious ...

2 Minute Read
Blogs |
November 8, 2010

5 Questions That May Help You Dodge Cancer

WASHINGTON— With growing financial and time pressures in medical care, the era of the leisurely doctor’s visit is largely gone.  As visits become increasin...

7 Minute Read
Blogs |
November 5, 2010

Promising Phase II Results for New Drug to Treat A...

Roche announced results from a Phase II clinical study of RG7204 (PLX4032), an inhibitor targeting the BRAF protein that is found in half of metastatic melanoma tumors.&nbs...

1 Minute Read
Melanoma News |
November 3, 2010

FDA Extends Deadline for Decision on Ipilimumab

The U.S Food and Drug Administration (FDA) extended its deadline for an approval decision on Bristol-Myers Squibb’s (BMS) drug for advanced melanoma, ipilimumab. ...

1 Minute Read
Blogs |
November 2, 2010

Melanoma Research Gets Boost from Washington, D.C....

WASHINGTON, D.C.— For years, treatment options for patients with advanced melanoma have been bleak, with survival averaging around one year after diagnosis.  But...

5 Minute Read
Blogs |
October 20, 2010

MRF to Young Adults: Debunk Melanoma Myths To Inc...

WASHINGTON, D.C.—Melanoma’s role as the number one form of cancer in young adults may be fueled by pervasive myths and misunderstandings about risk factors, and...

6 Minute Read
Blogs |
October 7, 2010

Respected Producer/Writer Succumbs to Melanoma

The Melanoma Research Foundation (MRF) is deeply saddened to learn of the loss of famed Hollywood producer and writer Stephen J. Cannell, who recently passed away from...

1 Minute Read

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

24th Annual New York Gala

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Nov 02, 2025 ET

Atlanta Miles for Melanoma 5K

Nov 09, 2025 ET

MRF Brain Metastases Summit 4.0

Nov 13, 2025 ET

DC Wings of Hope Reception

Nov 16, 2025 ET

San Francisco Miles for Melanoma 5K

Explore Events